Insider · CIK 0001875506
Rachid Izzar
Files at BIIB (BIOGEN INC.). First filing Jul 16, 2025, latest Jul 16, 2025.
In brief
Rachid Izzar files SEC Form 4 as officer at BIIB (BIOGEN INC.). Since Jul 16, 2025, Rachid Izzar has reported 0 open-market buys worth $0 and 1 open-market sell worth $300k, the latest filed on Jul 16, 2025.
A track record needs three past buys with six months of prices behind them; Rachid Izzar has 0, so none is measured yet.
The newest scored trade: sold $300k of BIIB on Jul 8, 2025, filed Jul 16, 2025, scored 19 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BIIB: BIOGEN INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | BIOGEN INC. | $300k 2,223 shares | -26% | +19% from low-33% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 8, 2025 | BIIB BIOGEN INC. | 2,223 0.00% of outstanding | $300k | Jul 8, 2025 | none |
Transactions
Every row this insider has filed, 36 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +7,390 | $0.00 | $0 | 7,390 | Feb 17, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,044 | $0.00 | $0 | 8,204 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -805 | $201.18 | $162k | 7,399 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,802 | $0.00 | $0 | 9,201 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -458 | $201.18 | $92k | 8,743 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +3,043 | $0.00 | $0 | 11,786 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -775 | $201.18 | $156k | 11,011 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,044 | $0.00 | $0 | 0 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,802 | $0.00 | $0 | 1,802 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -3,043 | $0.00 | $0 | 6,087 | Feb 10, 2026 |
| Jul 8, 2025 | BIIB BIOGEN INC. | SOpen-market sale Common Stock10b5-1 | -2,223 | $135.00 | $300k | 6,330 | Jul 16, 2025 |
| Feb 10, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,515 | $0.00 | $0 | 8,998 | Feb 12, 2025 |
| Feb 10, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -445 | $142.54 | $63k | 8,553 | Feb 12, 2025 |
| Feb 10, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,515 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,043 | $0.00 | $0 | 7,224 | Feb 11, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -600 | $141.35 | $85k | 6,624 | Feb 11, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -565 | $141.35 | $80k | 6,059 | Feb 11, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,801 | $0.00 | $0 | 7,860 | Feb 11, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,043 | $0.00 | $0 | 2,044 | Feb 11, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,801 | $0.00 | $0 | 3,604 | Feb 11, 2025 |
| Feb 6, 2025 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +9,130 | $0.00 | $0 | 9,130 | Feb 10, 2025 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,370 | $0.00 | $0 | 10,006 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -639 | $219.08 | $140k | 9,367 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +647 | $0.00 | $0 | 10,014 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -313 | $219.08 | $69k | 9,701 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Performance Stock Unitderivative | -1,370 | $0.00 | $0 | 0 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -647 | $0.00 | $0 | 807 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | JOther Restricted Stock Unitderivative | -807 | $0.00 | $0 | 0 | Feb 21, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,515 | $0.00 | $0 | 9,081 | Feb 13, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -445 | $240.98 | $107k | 8,636 | Feb 13, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,515 | $0.00 | $0 | 1,515 | Feb 13, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,043 | $0.00 | $0 | 8,187 | Feb 9, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -621 | $240.30 | $149k | 7,566 | Feb 9, 2024 |
| Feb 7, 2024 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +5,405 | $0.00 | $0 | 5,405 | Feb 9, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,043 | $0.00 | $0 | 4,087 | Feb 9, 2024 |
| Jan 29, 2024 | BIIB BIOGEN INC. | AGrant or award Performance Stock Unitderivative | +1,370 | $0.00 | $0 | 1,370 | Jan 31, 2024 |
Questions about Rachid Izzar
Answered from the filings on this page, as of the latest one.
Is Rachid Izzar buying or selling?
Not in the last 12 months. Rachid Izzar's latest open-market trade on SEC Form 4 was sold $300k of BIIB on Jul 8, 2025.
How did Rachid Izzar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rachid Izzar has 0.
Where does Rachid Izzar file Form 4?
Rachid Izzar has filed Form 4 at BIIB (BIOGEN INC.) as Head of Global Product Strat.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.